Active, not recruitingPhase 3NCT05723835
A Research Study Looking at How Safe Somapacitan is and How Well it Works in Children Who Need Help to Grow - REAL 9
Studying Turner syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Novo Nordisk A/S
- Principal Investigator
- Clinical Transparency (dept. 2834)Novo Nordisk A/S
- Intervention
- Somapacitan(drug)
- Enrollment
- 47 enrolled
- Eligibility
- 10-18 years · All sexes
- Timeline
- 2023 – 2027
Study locations (17)
- Univ of AL at Birmingham_BRM, Birmingham, Alabama, United States
- Sutter Valley Med Fdt Ped Endo, Sacramento, California, United States
- Rocky Mt Ped and Endo, Centennial, Colorado, United States
- Childrens National Medical Ctr, Washington D.C., District of Columbia, United States
- Rocky Mt Clin Res, LLC, Idaho Falls, Idaho, United States
- Children's Minnesota, Saint Paul, Minnesota, United States
- University Malaya Medical Centre, Lembah Pantai, Kuala Lumpur, Malaysia
- University Technology MARA (UiTM) - Sg Buloh, Bandar Puncak Alam, Selangor, Malaysia
- Erasmus MC, Rotterdam, Netherlands
- Kliniczny Szpital Wojewodzki nr 2 im. Sw. Jadwigi Krolowej w Rzeszowie, Rzeszów, Podkarpackie Voivodeship, Poland
- UCK, Klinika Pediatrii, Diabetologii i Endokrynologii,, Gdansk, Poland
- Instytut Centrum Zdrowia Matki Polki, Lodz, Poland
- Kliniczny Szpital Wojewodzki nr 2 im. Sw. Jadwigi Krolowej w Rzeszowie, Rzeszów, Poland
- SPSK nr 1 im. prof.S.Szyszko w Zabrzu, Zabrze, Poland
- Asan Medical Center, Seoul, South Korea
- +2 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05723835 on ClinicalTrials.govOther trials for Turner syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07502586Turner Syndrome: Genetic ConsiderationsEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- RECRUITINGPHASE3NCT07221851Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient DisordersAscendis Pharma A/S
- RECRUITINGNCT07344012Parental Project Amongst 93 Patients With Turner SyndromeUniversity Hospital, Strasbourg, France
- RECRUITINGPHASE4NCT06834594Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner SyndromeChildren's Mercy Hospital Kansas City
- RECRUITINGNCT06507007Genetic and Epigenetic Background of Inner Ear Dysfunction in Turner SyndromeGødstrup Hospital
- RECRUITINGNCT06794190Characterization of Hepatopathy in Turner Syndrome: Analysis of DeterminantsIRCCS Azienda Ospedaliero-Universitaria di Bologna
- RECRUITINGPHASE2NCT06668805A Basket Study of Vosoritide in Children With Turner Syndrome, Short Stature Homeobox-Containing Gene Deficiency, and Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone TreatmentBioMarin Pharmaceutical
- RECRUITINGPHASE2NCT05849389Vosoritide for Short Stature in Turner SyndromeRoopa Kanakatti Shankar, MBBS, MS